M&A Deal Summary |
|
---|---|
Date | 2011-01-19 |
Target | A2 Technologies |
Sector | Test/Measurement Equipment |
Buyer(s) | Agilent |
Deal Type | Add-on Acquisition |
Advisor(s) | OEM Capital (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1999 |
Sector | Test/Measurement Equipment |
Employees | 17,600 |
Revenue | 6.8B USD (2023) |
Agilent is a producer of solutions that includes instruments, software, services, and consumables for the entire laboratory workflow. Agilent's life sciences and applied markets business provide application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Agilent was founded in 1999 and is based in Santa Clara, California.
DEAL STATS | # |
---|---|
Overall | 13 of 38 |
Sector (Test/Measurement Equipment) | 4 of 9 |
Type (Add-on Acquisition) | 10 of 35 |
State (Connecticut) | 1 of 1 |
Country (United States) | 12 of 28 |
Year (2011) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-05-14 |
Varian
Santa Clara, California, United States Varian, Inc. is a worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,600 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. |
Buy | $1.5B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-03-01 |
BIOCIUS Life Sciences
Wakefield, Massachusetts, United States BIOCIUS Life Sciences, Inc. is a developer of the RapidFire high-throughput mass spectrometry drug-screening platform for the pharmaceutical and biopharmaceutical markets. |
Buy | - |